Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization

Journal of Drug Targeting

Volumn 20, Issue 1, 2012, Pages 76-84

  Malik, Basant ^a   Goyal, Amit K ^a   Markandeywar, T S ^a   Rath, Goutam ^a   Zakir, Foziyah ^a   Vyas, Suresh P ^b  

^a ISF COLLEGE OF PHARMACY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

alginate; chitosan nanoparticles; M cell targeting; Oral immunization; vaccines

Indexed keywords

ALGINIC ACID; ALUMINUM HYDROXIDE; BOVINE SERUM ALBUMIN; CHITOSAN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; ULEX EUROPAEUS AGGLUTININ; VACCINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HYDROLYSIS; IMMUNE RESPONSE; IN VITRO STUDY; INTESTINE LYMPHATIC TISSUE; MUCOSAL IMMUNITY; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; CATTLE; CELL ENGINEERING; CHITOSAN; DRUG DELIVERY SYSTEMS; MICE; MICE, INBRED BALB C; NANOPARTICLES; POLYMERS; PROTEIN STABILITY; SURFACE PROPERTIES; VACCINATION;

EID: 83155183262     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2011.611516     Document Type: Article

References (31)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. (2000). Immunobiology of dendritic cells. Annu Rev Immunol, 18, 767-811. (Pubitemid 30365397)
2. Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger HE. (2005). Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm, 299, 155-166. (Pubitemid 40962417)
3. Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. (2004). A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release, 96, 285-300.
4. Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH. (1993). Differential expression of lectin-binding sites defines mouse intestinal M-cells. J Histochem Cytochem, 41, 1679-1687. (Pubitemid 23317114)
5. + T cell responses: the alternative approaches. Annu Rev Immunol, 15, 297-322. (Pubitemid 27169283)
6. Cremer BK, Kreuter J. (1996). Preparation and characterization of chitosan microsphere as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release, 39, 17-25. (Pubitemid 26139808)
7. Dobakhti F, Rahimi F, Dehpour AR, Taghikhani M, Ajdary S, Rafiei S, Rafiee-Tehrani M. (2006). Stabilizing effects of calcium alginate microspheres on Mycobacterium bovis BCG intended for oral vaccination. J Microencapsul, 23, 844-854. (Pubitemid 46332096)
8. George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Release, 114, 1-14. (Pubitemid 44131680)
9. Goyal AK, Khatri K, Mishra N, Vyas SP. (2008). New patents on mucosal delivery of vaccines. Expert Opin Ther Patents, 18, 1-18.
10. Gullberg E, Keita AV, Salim SY, Andersson M, Caldwell KD, Söderholm JD, Artursson P. (2006). Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyers patches. J Pharmacol Exp Ther, 319, 632-639.
11. Gupta PN, Khatri K, Goyal AK, Mishra N, Vyas SP. (2007). M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target, 15, 701-713. (Pubitemid 350201323)
12. Hejazi R, Amiji M. (2002). Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. Int J Pharm, 235, 87-94. (Pubitemid 34185439)
13. Holmgren J, Czerkinsky C. (2005). Mucosal immunity and vaccines. Nat Med, 11, S45-S53. (Pubitemid 40562303)
14. Jain AK, Goyal AK, Gupta PN, Khatri K, Mishra N, Mehta A, Mangal S, Vyas SP. (2009). Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release, 136, 161-169.
15. Jain S, Singh P, Mishra V, Vyas SP. (2005). Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett, 101, 41-49. (Pubitemid 41297497)
16. Kim CK, Lee EJ. (1992). The controlled release of blue dextran from alginate beads. Int J Pharm, 79, 11-19.
17. Liu X, Chen D, Xie L, Zhang R. (2003). Oral colonspecific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. J Control Release, 93, 293-300.
18. van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J, Junginger HE. (2003). Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine, 21, 1400-1408. (Pubitemid 36263181)
19. Malik B, Goyal AK, Mangal S, Zakir F, Vyas SP. (2010). Implication of gut immunology in the design of oral vaccines. Curr Mol Med, 10, 47-70.
20. McKenzie BS, Brady JL, Lew AM. (2004). Mucosal immunity: overcoming the barrier for induction of proximal responses. Immunol Res, 30, 35-71. (Pubitemid 38998649)
21. Mishra N, Tiwari S, Vaidya B, Agrawal GP, Vyas SP. (2011). Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target, 19, 67-78.
22. Montalbetti CAGN, Falque V. (2005). Amide bond formation and peptide coupling. Tetrahedron, 61, 10827-10852. (Pubitemid 41447509)
23. Neutra MR, Frey A, Kraehenbuhl JP. (1996). Epithelial M cells: gateways for mucosal infection and immunization. Cell, 86, 345-348. (Pubitemid 26272074)
24. Schnurch AB, Humenberger C, Valenta C. (1998). Basic studies on bioadhesive delivery systems for peptide and protein drugs. Int J Pharm, 165, 217-225. (Pubitemid 28239708)
25. Shargel L, Yu A. (1999). Applied Biopharmaceutics and Pharmacokinetics, 4th ed., chapter 5, New York,USA: Mc Graw Hill publisher.
26. Sugawara S, Imai T, Otagiri M. (1994). The controlled release of prednisolone using alginate gel. Pharm Res, 11, 272-277. (Pubitemid 24076223)
27. Tiyaboonchai W. (2003). Chitosan Nanoparticles: A Promising System for Drug Delivery. Naresuan University Journal, 11, 51-66.
28. Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. (2002). Design of biodegradable particles for protein delivery. J Control Release, 78, 15-24. (Pubitemid 34081849)
29. Wang GQ, Cochrane T, McCarron P. (2005). Modulation of surface charge, particle size and morphological properties of chitosan TPP nanoparticles intended for gene delivery. Colloids Surf B, 44, 65-73. (Pubitemid 41111534)
30. Wang W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm, 185, 129-188. (Pubitemid 29392904)
31. Yotsuyanagi T, Ohkubo T, Ohhashi T, Ikeda K. (1987). Calcium induced gelation of alginic acid and pH-sensitive reswelling of dried gels. Chem Pharm Bull, 35, 1555-1563. (Pubitemid 17064909)